Bill Baruch on What He’s Watching in Nvidia’s Print
Bill Baruch has outlined his checklist prior to Nvidia’s report, focusing on initial Rubin deliveries, Blackwell efficiencies, margins, and memory costs. He is particularly interested in management’s comments on the financing deal and anticipates potential positive surprises from the non-GPU business, AI models, and CPU products.
Bill Baruch Adds to Nvidia Ahead of the Print and Builds Out Oracle
Bill Baruch called in to Halftime to walk through two AI infrastructure moves. He added to Nvidia ahead of earnings, saying he was underweight relative to the S&P and bumped the position to 8.25 percent. He likes the setup at 20 times forward against earnings growth above 100 percent, and with the 500 billion dollar […]
Bill Baruch’s Final Trade: Amgen’s Six Growth Drivers Are Blowing It Out
Bill Baruch says AppLovin’s pullback looks like an opportunity. He owns the name and pointed out that the quarter three forecast came in largely in line, with the big AI tailwind still fully intact. What moved the stock, in his read, was the absence of another blowout guide rather than anything breaking in the story, […]
Bill Baruch on SpaceX: Buying the Unlock and Looking Past Starlink
Bill Baruch says he has been buying SpaceX personally over the past week, and his approach is to put it away and let the story develop over the next six months. While most of the market leans on Starlink and the data centers in space narrative, Bill thinks the compute side is where the real […]
Bill Baruch’s Three Pillars: Why He Sees the S&P at 8,000
Bill Baruch laid out the three factors he flagged to clients two weeks ago, back when the SMH was roughly 25 percent off its highs and he thought the selloff was overdone. First, the Fed is misunderstood. He believes hawkish expectations are offsides, pointing to Powell’s comment that oil price shocks are not something monetary […]
Bill Baruch Likes AbbVie’s Breakout as Humira Losses Get Replaced
Bill Baruch is looking at AbbVie as a healthcare name outside of the tech trade. He pointed to 7 percent earnings growth and an expected 24 percent revenue growth ahead, with Skyrizi and Rinvoq now making up for the revenue AbbVie lost as Humira came off patent. The stock is only up about 7 percent […]
Bill Baruch’s Final Trade: Nebius Group Set to Snap Back
Bill Baruch joined CNBC’s Halftime Report for his final trade, picking Nebius Group. He calls it an AI infrastructure name with an ultra growth story that has sold off nearly half from its recent high into major support. He thinks that it snaps back quickly, though he flagged it as one of the more volatile […]
Micron’s Pop Signals Capitulation on CapEx Fears, Says Bill Baruch
Bill Baruch flagged Micron as a signal he’s been watching for a couple of weeks. After its last earnings report, memory stocks including Micron ran the following day, and he reads that move as capitulation on the market’s fear around AI CapEx spending. It’s part of a broader thesis he holds on the Mag Seven […]
Bill Baruch Defends His Gold Trade: Rebalancing Into Miners and Betting the Fed Blinks
Bill Baruch joined CNBC’s Halftime Report to defend his gold position after a rough quarter for the metal. Earlier this year, he trimmed GDX and sold CEF, a gold and silver combo fund, to move into OUNZ, a gold only vehicle. Now he says he’s stepping back in to buy more of both GDX and […]
This Selloff Looks Like August — Bill Baruch Stays Bullish but Wants Proof
Bill Baruch thinks the selloff got exacerbated — exploding put volume, leveraged ETF selling, and profit-taking after tech charts ran straight up to the right. He’s comparing it to August 2024’s sharp drop that became the low before the summer rally kicked in. But he’s not fully convinced yet: he needs to see healthcare and […]